Source: European & Developing Countries Clinical Trials Partnership (EDCTP) |

Joint Press Release: Europe-Africa partnership spearheads development of next-generation antimalarial drug

The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and Niger

The European & Developing Countries Clinical Trials Partnership (EDCTP) (www.EDCTP.org) grants €10 million over five years to “WANECAM 2” a unique collaboration between antimalarial drug researchers in Africa and Europe from ten academic institutions, a pharmaceutical company, Novartis, and a not-for-profit product development partnership (PDP), Medicines for Malaria Venture; the grant will…